Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B V Clineschmidt

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Journal of Medicinal Chemistry|March 1, 1982
Synthesis and orexigenic activity of some 1-methyl-4-piperidylidene-Substituted pyrrolo[2,1-g][3] benzazepine and dibenzocycloheptene derivativesD C Remy, S F Britcher, P S Anderson, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1987
Roles of endogenous cholecystokinin in biliary, pancreatic and gastric function: studies with L-364,718, a specific cholecystokinin receptor antagonistR G Pendleton, R J Bendesky, L Schaffer, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1984
Pharmacologic profile of a novel potent direct-acting dopamine agonist, (+)-4-propyl-9-hydroxynaphthoxazine [(+)-PHNO]G E Martin, M Williams, D J Pettibone, et al.
Life Sciences|May 24, 1982
Potent dopamine agonist activity of a novel ergoline, 6-ethyl-9-oxaergoline (EOE)G E Martin, M Williams, B V Clineschmidt, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1987
In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonistV J Lotti, R G Pendleton, R J Gould, et al.
Annals of the New York Academy of Sciences|June 12, 1978
Fenfluramine and brain serotoninB V Clineschmidt, A G Zacchei, J A Totaro, et al.
Journal of Medicinal Chemistry|December 1, 1977
(+)- and (-)-3-Methoxycyproheptadine. A comparative evaluation of the antiserotonin, antihistaminic, anticholinergic, and orexigenic properties with cyproheptadineD C Remy, K E Rittle, C A Hunt, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1979
Stereospecific antidopaminergic and anticholinergic actions of the enantiomers of (+/-)-1-cyclopropylmethyl-4-(3-trifluoromethylthio-5H-dibenzo[a,d]cyclohepten-5-ylidene) piperidine (CTC), a derivative of cyproheptadineB V Clineschmidt, M A McKendry, N L Papp, et al.
Life Sciences|January 1, 1989
[3H]L-657,743 (MK-912): a new, high affinity, selective radioligand for brain alpha 2-adrenoceptorsD J Pettibone, S D Flagg, J A Totaro, et al.
Regulatory Peptides|April 29, 1993
Development and pharmacological assessment of novel peptide and nonpeptide oxytocin antagonistsD J Pettibone, B V Clineschmidt, M G Bock, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Journal of Medicinal Chemistry|March 1, 1982
Synthesis and orexigenic activity of some 1-methyl-4-piperidylidene-Substituted pyrrolo[2,1-g][3] benzazepine and dibenzocycloheptene derivativesD C Remy, S F Britcher, P S Anderson, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1987
Roles of endogenous cholecystokinin in biliary, pancreatic and gastric function: studies with L-364,718, a specific cholecystokinin receptor antagonistR G Pendleton, R J Bendesky, L Schaffer, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1984
Pharmacologic profile of a novel potent direct-acting dopamine agonist, (+)-4-propyl-9-hydroxynaphthoxazine [(+)-PHNO]G E Martin, M Williams, D J Pettibone, et al.
Life Sciences|May 24, 1982
Potent dopamine agonist activity of a novel ergoline, 6-ethyl-9-oxaergoline (EOE)G E Martin, M Williams, B V Clineschmidt, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1987
In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonistV J Lotti, R G Pendleton, R J Gould, et al.
Annals of the New York Academy of Sciences|June 12, 1978
Fenfluramine and brain serotoninB V Clineschmidt, A G Zacchei, J A Totaro, et al.
Journal of Medicinal Chemistry|December 1, 1977
(+)- and (-)-3-Methoxycyproheptadine. A comparative evaluation of the antiserotonin, antihistaminic, anticholinergic, and orexigenic properties with cyproheptadineD C Remy, K E Rittle, C A Hunt, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1979
Stereospecific antidopaminergic and anticholinergic actions of the enantiomers of (+/-)-1-cyclopropylmethyl-4-(3-trifluoromethylthio-5H-dibenzo[a,d]cyclohepten-5-ylidene) piperidine (CTC), a derivative of cyproheptadineB V Clineschmidt, M A McKendry, N L Papp, et al.
Life Sciences|January 1, 1989
[3H]L-657,743 (MK-912): a new, high affinity, selective radioligand for brain alpha 2-adrenoceptorsD J Pettibone, S D Flagg, J A Totaro, et al.
Regulatory Peptides|April 29, 1993
Development and pharmacological assessment of novel peptide and nonpeptide oxytocin antagonistsD J Pettibone, B V Clineschmidt, M G Bock, et al.
Pageof 8